Deep generative design and structure-based evaluation of celecoxib-inspired PTGS2/COX-2 ligands: a computational study in the context of adenomyosis-associated inflammation
Adenomyosis is a chronic inflammatory gynecological disorder in which cyclooxygenase-2 (PTGS2/COX-2)-derived prostaglandin signaling contributes to inflammation. This study asked whether deep learning-based generative modification of the celecoxib scaffold yields compounds with a more favorable predicted interaction profile at PTGS2. A generative platform combining a three-dimensional convolutional neural network with a conditional variational autoencoder returned twelve analogues, all carried forward without post hoc selection and examined by substructure analysis, docking at the experimentally defined ligand-binding site, pharmacophore comparison, ADMET and toxicity prediction, density functional theory, and 200 ns molecular dynamics with MM/GBSA estimation. The benzenesulfonamide group of celecoxib was retained in five of twelve analogues and the trifluoromethyl-pyrazole core in none, so the compounds are better described as scaffold-hopped analogues than as close derivatives. AI Analogue 2 returned the most favorable predicted binding energy (− 10.024 kcal/mol; celecoxib − 7.748 kcal/mol) and formed a persistent complex with an effective binding energy of − 51.89 kcal/mol. Its predicted pose lies along the main cyclooxygenase channel rather than the COX-2 side pocket occupied by celecoxib, so the two energies are not comparable as affinities. Redocking of the co-crystallized ligand gave a deviation of 1.924 Å and the celecoxib trajectory did not converge, indicating a rigid-receptor starting-pose artifact rather than a property of the generated compounds. Predicted blood–brain barrier permeability coincided with an active neurotoxicity call, identifying central exposure as the principal predicted liability. The study does not establish COX-2 inhibition, selectivity over COX-1, improved safety, or therapeutic activity in adenomyosis .
Authors
- Nouman Safdar Ali (ORCID: https://orcid.org/0009-0001-1979-7166)
- Sibel Üstünel (ORCID: https://orcid.org/0000-0002-4096-0562)
Institutions
- Atlas Üniversitesi (TR)
Publication Details
- Journal
- Scientific Reports
- Published
- 2026-11-16
- DOI
- https://doi.org/10.1038/s41598-026-75822-4
- Primary Topic
- Computational Drug Discovery Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.00